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ABSTRACT 
Lung cancer is the most frequent malignant tumour with the highest mortality rate around the world, leading to greater than a million deaths 
annually. The number of deaths due to lung cancer is expected to increase to ten million deaths per year in 2030. The major risk factor for the 
development of lung cancer is cigarette smoking but relatively high rates of lung cancer occur among non-smoking women and 10-25% of lung 
cancer observed in never smokers. The lung cancer deaths occur in never smokers have been estimated to be the 7th leading cause of cancer 
mortality. This article mainly discusses the important etiological factors of lung cancer in never smokers such as the environmental factors, 
occupational exposure, history of lung disease, family history and genetic factors, unbalanced diet and high consumption of saturated fat, radiation 
exposure, socioeconomic status, and infections. Gender, obesity and metabolic syndrome, race and ethnicity and interstitial lung diseases also have 
effects on the development of lung cancer in never smokers. 
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Cancer is considered as one of the major distressing disease 
worldwide and out of many cancers, lung cancer is one of the serious 
health problem [1, 2]. In the early 1900s lung cancer was a rare 
disease, but now it’s becoming the most common cause of cancer 
death worldwide [3]. In the year 2012, about 1.8 million new cases 
of lung cancer were diagnosed, which accounted for 12.9% of the 
world’s total cancer incidence [4]. Lung cancer considered as the 
most fatal forms of cancer because lack of proper diagnosis and lack 
of effective treatments and it accounts for more deaths than any 
other cancer types [5, 6]. The GLOBOCAN 2018 estimated that in 
both sexes combined, lung cancer is the most commonly 
diagnosed cancer (11.6% of the total cases) and the leading cause 
of cancer death (18.4% of the total cancer deaths), closely followed 
by female breast cancer (11.6%), prostate cancer (7.1%), and 
colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), 
stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung 
cancer is the leading cause of cancer death among males followed by 
prostate and colorectal cancer (for incidence) and liver and 
stomach cancer 
In India also it is a one of the major health care problem [12]. It is 
commonest in men in India accounting for 11.3% of all new cancers 
and also is the most common cause of cancer death (13.7%). In 
different parts of India, the various demographic profiles such as 
age, sex, stage, history, and even the molecular epidemiology varies 
considerably. However, as compared to many western countries the 
overall incidence is much lower [13]. 
(for mortality) [7]. Even though in some countries 
the declining trends in the incidence of lung cancer was reported, it 
will continue to be a major cause of death through the world [8]. The 
number of deaths due to lung cancer is expected to increase to ten 
million deaths per year in 2030 [9]. Lung cancer is mainly found 
malignancy in males, and is becoming increasingly common among 
female gender [10]. Lung cancer incidence and mortality rate among 
male is 3 times higher than in females [11]. 
Lung cancer mainly originates from the basal epithelial cells and is 
mainly classified into two types, non-small cell lung cancer (NSCLC) 
and small cell lung cancer (SCLC). Among these NSCLC is more 
common and which accounts for approximately 85% of lung cancer 
cases, with adenocarcinoma accounting for 40% of the total and 5-
10% is large cell carcinoma [5, 14]. Lung cancer has a low survival 
rate (with an overall 5-year survival rate of 10% to 15%) because 
most patients are diagnosed at a late stages and have a poor 
prognosis [15]. 
The major risk factor for the development of lung cancer is cigarette 
smoking but relatively high rates of lung cancer occur among non-
smoking women and 10-25% of lung cancer observed in never smokers 
[2, 16, 17]. The lung cancer deaths occur in never smokers have been 
estimated to be the 7th leading cause of cancer mortality [18]. In an 
epidemiological view, lung cancer in never smokers is now considered as 
a distinct disease entity. In India, increase in the number of lung cancer 
cases among never smokers is evident [19]. The geographic variation 
affects the incidence of lung cancer in never smokers [20]. 
The adenocarcinoma has surpassed squamous cell carcinoma as the 
most histologic variant of lung cancer in western countries and most 
of the Asian countries. The main reason for this shift is the changed 
smoking pattern and increasing incidence of lung cancer in females 
and never smokers [6]. 
As we found that lung cancer in never smokers is a distinct disease 
entity and that is more frequent in women than in men and in 
certain geographical regions than in other (Asia>North 
America>Europe). The environmental factors such as outdoor and 
indoor air pollution and occupational exposure were an important 
risk factor for the development of lung cancer in these population 
[21]. The other major risk factors considered important for never 
smokers include other environmental exposure, history of lung 
disease, family history and genetic factors, unbalanced diet and high 
consumption of saturated fat, radiation exposure, socioeconomic 
status, and infections. Gender, obesity and metabolic syndrome, race 
and ethnicity and interstitial lung diseases also have effects on the 
development of lung cancer in never smokers [2, 4, 19, 22, 23]. 
Environmental factors 
Even though tobacco smoking is the major cause for the 
development of lung cancer, the environmental cause of lung cancer, 
including air pollution have long been a concern. There is a clear 
epidemiological evidence that suggests a considerable association 
between air pollution and lung cancer, but the rate is small as 
compared with cigarette smoking [2]. It is reported that in males 
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who had no family history of cancer and who were never smokers, 
but exposed to high environmental pollutants, the odds ratio was 6.8 
for the risk of developing lung cancer [19]. 
The contribution of air pollution exposure estimated to 62,000 lung 
cancer death per year worldwide [2]. Air pollution is responsible for 
5-7% of lung cancer in non-smokers [19]. So far, air pollution studies 
that have examined the relationship with lung cancer have mainly 
been one in Europe and North America, although in recent years 
several studies also carried out on other continents and the results 
also show the association between air pollution and lung cancer risk 
[24]. In developing countries like India, the studies that found the 
relation between lung cancer and air pollution is very less, and 
therefore opportunities to strengthen the scientific evidence on air 
pollution and lung cancer should be pursued. 
Indoor air pollution mainly resulting from the incomplete 
combustion of solid fuels such as wood, coal, agricultural waste, 
charcoal and animal dung for cooking and or heating is major global 
public health concern [25]. Indoor air pollution consists of complex 
mixture of pollutants including particulate matter, sulphur oxides, 
nitrogen oxides, carbon monoxide, polycyclic aromatic 
hydrocarbons, formaldehyde, and dioxins, to name few [26]. The use 
of indoor combustion products is extremely high in Africa and South 
East Asia when compared to the developed regions such as the US 
and European countries [19]. The non-smoking women chronically 
exposed to cooking fumes generated from burning wood or frying fat 
at high temperatures in China and these women appears to be at 
increased risk of lung cancer, especially adenocarcinoma [27]. 
A significant relation between lung cancer and using solid fuel for 
cooking was established by a case-control study that conducted in 
Japan (RR=1.8, 95% CI: 1.1-2.9). Similar studies were also conducted 
in the Northern Provinces of South Africa, results were also same 
and the OR of lung cancer among using wood or coal as main fuel 
was 1.4 (95% CI: 0.6-3.2) [2]. A study carried in Guangzhou and in 
other Chinese cities implied an association between indoor air 
pollution and the incidence of lung cancer deaths in females [28]. 
The data available from other regions of the world that supporting a 
similar effect of exposure to cooking and heating-derived indoor air 
pollution is limited [2]. The findings of Ole Raaschou-Nielsen and 
colleagues from individual data from 17 European cohorts 
presented in the Lancet Oncology showed that exposure to 
particulate matter air pollution increased the risk of lung cancer 
particularly adenocarcinoma [24]. 
Outdoor air pollution increases the risk of lung cancer [20]. The vehicle 
exhaust, heating systems, and industrial burning waste are the main 
sources of outdoor air pollution [4]. The quality of air decrease by the 
release of these industrial fumes and vehicular exhausts and many 
studies have reported the association of lung cancer risk and air quality 
[19]. In a study that conducted by Raaschou-Nielsen et al. found that 
non-smokers and residents near heavy traffic roads are at a high risk of 
air pollution associated with lung cancer. Moreover, they reported that 
nitrogen oxide and nitrogen dioxide emitted from the vehicle engine 
exhaust are the major etiological factor for the development of lung 
cancer in urban population [29]. 
Nyberg and colleagues conducted a case-control study in Sweden and 
found a relative risk for lung cancer of 1.44 for persons exposed to 
more than 29.3 µg/m3 of nitric oxide (as a measure of traffic air 
pollutant) over 21 to 30 y compared with exposures to lower than 12.8 
µg/m3 of nitric oxide [30]. The another important component of air 
pollution is considered as diesel exhaust and one study implied a 
strong support especially in persons in the trucking industry that 
occupational exposure to diesel exhaust is associated with an 
approximately 30% to 50% increase in the relative risk of lung cancer 
[20]. Some studies reported that exposure to sulphur dioxide in the 
paper and pulp industry increases the chances of lung cancer [31]. 
Environmental tobacco smoke (ETS); over the last years, the role 
of ETS in the causation of lung cancer has been repeatedly evaluated 
[2]. Today, the association between ETS and lung cancer has been 
largely reported [21]. A study conducted by Elisabetta Rapiti et al. in 
Chandigarh, India and this study suggests that ETS exposure may be 
a strong risk factor for lung cancer [32]. A large number of 
epidemiologic studies on the risk for lung cancer in non-smokers is 
conducted and the summary analysis of these studies found an 
excess risk for lung cancer of 24% in non-smokers who lived with a 
smoker [33]. 
In a study that conducted in non-smoking women found that tobacco 
use by the spouse was associated with a 30% excess risk for all types 
of lung cancer [33]. International agency for research on cancer 
(IARC) concluded from the review of numerous studies that 
involuntary smoking is carcinogenic to humans, with an increased 
risk of 20% for women and of 30% of men among never smokers 
who are exposed to second-hand smoke (i.e., environmental tobacco 
smoke) from their spouse [34]. In a meta-analysis of 55 recent 
studies of spousal smoking on the lung cancer risk demonstrated 
that the non-smoking spouse showed a pooled relative risk of 1.27 
(95% CI: 1.17-1.37) with risk increasing monotonically with 
increasing exposure [18]. 
Occupational factors 
Lung cancer is considered as the most occupationally acquired 
malignancy among the various types of cancers [19]. Worldwide, 
due to occupational exposure to the carcinogen, there are estimated 
152,000 deaths from lung cancer and approximately 1.6 million 
disability-adjusted life years from lung cancer [20]. There are 12 
occupational factors as being identified as carcinogenic to human 
lung by international agency for research on cancer (IARC) and these 
include aluminium production, arsenic, asbestos, bis-chloromethyl 
ether, beryllium, cadmium, hexavalent chromium, coke and coal 
gasification fumes, crystalline silica, nickel, radon and soot [4]. The 
important factors are explained below. 
Asbestos is a well-established carcinogen among all occupational 
cancer causing agents and exposure to this compound at high levels 
can cause mesothelioma and lung cancer. Asbestos present in 2 
forms: Serpentine (i.e., chrysotile) and amphibole (i.e., actinolite, 
amosite, anthophyllate, crocidolite, and tremolite) [35]. The risk that 
associated with asbestos exposure for the development of lung 
cancer is dose dependent but varied with the type of asbestos fibre 
exposure. The risk for lung cancer seems lower for workers exposed 
to chrysotile fibres than for those exposed to amphibole fibres, after 
adjusting for similar exposure levels. Recent studies have shown 
that asbestos exposure was associated with a relative risk for lung 
cancer of 3.5 after adjusting for age, smoking and vitamin intake. The 
observed carcinogenic effect of asbestosis clearly potentiated by 
tobacco smoking, however, the magnitude of this combined effect is 
not clear. One study found that the relative risk for lung cancer with 
cigarette smoking alone 11 fold, with asbestos exposure alone, is 6 
fold, but with exposure to both asbestos and cigarette smoke, the 
increase may be as high as 59-fold [20]. 
Arsenic is said to be both an occupational and environmental lung 
carcinogen [36]. In never smokers, arsenic exposure is strongly 
associated with lung cancer and in these individual’s distinct 
mutational profile was observed [19]. Occupational exposures of 
arsenic that occurs primarily among workers whom breath dust 
from lead, gold, and copper ore mines and smelters [36]. The fairly 
constant exposure to arsenic via inhalation increases lung cancer 
risk is found by IARC from various cohort and nested case-control 
studies [37]. Clement-Duchene et al. found that gender was an 
important element of these occupational risk factor, 48.6% of men 
were exposed to occupational carcinogens versus 9.4% of women 
(P<0.0005) [38]. 
Chromium compounds; Hexavalent chromium (chromium VI) 
compounds that are produced primarily from industrial processes 
are classified as Group 1 lung carcinogens. From a review of more 
than 25 cohort studies, the IARC concluded that there was sufficient 
evidence in humans for the lung carcinogenicity of chromium (VI) 
compounds especially for highly exposed workers in the chromate 
production, chromate pigment production, and chromium plating 
industries [36]. 
Nickel compounds; nickel is a naturally occurring silvery white 
metal and the potential for low-level atmospheric nickel exposure 
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occurs from natural (e. g., windblown dust, volcanoes, and wildfires) 
and anthropogenic activities (e. g., mining, refining, smelting, 
manufacture of nickel-containing alloys and stainless steel). After a 
detailed review of pertinent epidemiologic studies, The IARC working 
group found that there is strong evidence for the carcinogenicity of 
nickel compounds [36]. 
 
Table 1: Group 1 IARC carcinogens with sufficient evidence of causing lung cancer in humans and primary type of exposure 
Agent Primary exposure type References 
Ionizing Radiation-all types  
 Alpha-particle emitters 
• Radon-222 and its decay products 
• Plutonium-239 









Chemicals and mixtures   
 Bis (Chloromethyl) ether; Chloromethyl methyl ether 
 Coal-tar pitch 
 Soot 
 Sulphur mustard 











Occupations   
 Aluminium Production 
 Coal gasification 
 Coke production 
 Iron and steel founding 
 Painting 













Metals   
 Arsenic and inorganic arsenic compounds 
 Cadmium and cadmium compounds 
 Beryllium and beryllium compounds 
 Chromium (VI) compounds 











Dust and fibres   
 Asbestos (all forms) 





Personal habits   
 Coal, indoor emission from household combustion 





Abbreviations: E, environmental exposure; O, Occupational exposure  
 
Rubber manufacturing industry in Rubber manufacturing 
industry, Rubber production workers are exposed to fumes with a 
complex chemical composition produced during the heating, curing 
of rubber compounds and also in vulcanizing process [36]. Many 
retrospective cohort mortality studies reported that increased lung 
cancer risks among rubber workers involved with mixing and 
milling, vulcanization and in cohorts of workers exposed to high 
concentrations of fumes and/or solvents and based on this the IARC 
workgroup concluded that there was sufficient evidence in humans 
for the carcinogenicity of occupational exposures in the rubber 
manufacturing industry [39]. 
Painting various paints consist of hundreds of hazardous chemicals 
including dichloromethane, di isocyanates, amines, esters, 
chromates, nickel etc. and the painters continue to have the potential 
for exposure to these chemicals. In between the year 1951 and 2010, 
more than 50 epidemiologic studies (i.e., cohort and case-control) 
were published and that overall demonstrates a relatively consistent 
increased risk of developing lung cancer for painters [36]. 
Diesel engine exhaust is both environmental and occupational 
factor for the development of lung cancer. The occupations that are 
known to have increased risk of exposure to diesel exhaust include 
underground miners, truck and bus drivers, toll booth attendants, 
construction workers etc. [40]. After the review of available 
literature, the IARC workgroup added diesel engine exhaust as a 
Group I carcinogen on June 12, 2012 [36]. 
Soot is the carbonaceous by-product material which produced by the 
incomplete conversion of fossil fuel or other carbon-containing material 
(e. g., paper, plastics) to combustion products (e. g., water vapour, CO2). 
The main constituents of soot are up to 60% carbon, inorganic material 
and a soluble fraction consisting primarily of PAHs. The higher potential 
for soot exposure is mainly occurs from the occupations like chimney 
sweeps, fire-fighters, brick masons and helpers; and others that require 
work near where organic matter is burned [41]. A standardized 
incidence ratio of 1.49 (95% CI: 1.3-1.7) for lung cancer for chimney 
sweeps reported from a study that published in 2009 from Denmark, 
Finland, Norway, and Sweden, a total of 212 incident lung cancer were 
observed in chimney sweeps [42]. 
Coal-tar pitch is a solid residue that produced from the distillation of 
coal tars. The major part of coal-tar consists of 3-membered to 7-
membered polycyclic aromatic hydrocarbons (PAHs), as well as their 
methylated derivative with lower concentrations of phenolic compounds 
and nitrogen bases. From various epidemiologic studies of road pavers 
and roofers, IARC working groups determined that there was sufficient 
evidence to support the carcinogenicity of coal-tar pitch [36]. 
Sulphur mustard in the military sector is called mustard gas, is 
primarily a chemical warfare agent. The exposure to sulphur mustard 
can also occur during its storage and destruction or from inadvertent 
exposure near dumping areas or areas where contamination may have 
occurred in the past (e. g., military installations, demolition of old 
buildings). The carcinogenicity of sulphur mustard is firmly established 
from findings of numerous studies performed between 1950 and 2000 
detailing the adverse effects of short-term battlefield exposure and 
prolonged exposure in chemical factories [43]. 
Bis (chloromethyl) ether (BCME); technical-grade chloromethyl 
methyl Ether (CMME); The IARC states that BCME is among the 
most potent human carcinogen known based on numerous studies 
of exposed workers. Statistically significant increases in the relative 
risks for lung cancer for exposure to BCME was reported from six 
epidemiologic studies performed in 1970 [36]. Manufacturing of 
BCME and technical-grade CMME were conducted widely before 
1976 in the US, but the use of these chemicals has been reduced 
substantially in the United States because of their lung 
carcinogenicity [43]. 
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Other Occupational carcinogens the occupations related with 
aluminium production, coke production, coal gasification, iron and 
steel founding also causes exposure to these carcinogens and may 
leading to the development of lung cancer. The exposure to metals 
like beryllium and beryllium compound, cadmium and cadmium 
compounds may also lead to the development of lung cancer [36]. 
Radiation 
Radiation plays an important role in the development of lung cancer 
[44]. The exposure to high doses of radiation is associated with lung 
cancer is reported by various epidemiologic studies. However, the 
development of lung cancer with the exposure to low dose radiation 
is still unclear [45]. All types of ionizing radiation cause 
carcinogenesis in humans and these are coming under IARC Group 1 
carcinogens [46]. The low linear energy transfer radiation (e. g., x-
rays, gamma rays) and high linear energy transfer radiation (e. g., 
neutrons, radon) are relevant to lung cancer) [45]. 
Radon is an inert gas and that is produced naturally from radium in 
the decay series of uranium [4]. Radon-222 decay products and 
Plutonium-239emits alpha-particles and these radionuclides are 
classified as Group 1 carcinogen by IARC [36]. Radon-222 and its 
decay products include polonium 218 and polonium 214 are the 
oldest known occupational carcinogens. After inhalation of these 
radon decay products, subsequent emission of alpha particle occurs 
in the lungs which may cause damage to cells and genetic material 
[20, 36]. Apart from outdoors, radon can also present in 
underground structures, such as mines, as well as built 
environments, such as homes, offices, and schools [47]. The possible 
risk for lung cancer in the general population associated with radon 
exposure has been a concern in recent years [20]. 
About 20,000 lung cancer deaths occur in the United States each year 
which are radon-related. The chronic exposure to radon contributes to 
the occurrence of lung cancer is found by three cohort studies 
conducted in Europe, North America, and China. The relative risk of 
lung cancer in the observed radon concentrations greater than per 100 
Bq/m3 was 8% (95% CI: 3-6%), 11% (95% CI: 0-28%), and 13% 
(95% CI: 1-36%), respectively [4]. A meta-analysis suggests a linear 
exposure-response relationship among smokers and in case of 
individual studies related with radon yield inconsistent results. A 
meta-analysis of 13 European studies is conducted to examine the 
impact of residential radon gas exposure on lung cancer risk and the 
results showed a greater absolute hazard to cigarette smokers and 
recent ex-smokers than to lifelong non-smokers [27]. 
X-rays and gamma rays 
Based primarily on the findings of the life span studies (LSS) of 
atomic bomb survivors in Hiroshima and Nagasaki, Japan; the IARC 
classified X-rays and gamma rays as Group 1 lung carcinogens in 
2000. Based primarily on findings from the LSS cohort as well as 
with supplemental findings from populations exposed to medical 
procedures, the recent 2012 IARC monograph continues to update x-
ray and γ-ray cancer risk estimate [36]. 
Family history 
As we know that the major cause of lung cancer is smoking and air 
pollution, however, genetic factors also contribute to the development 
of lung cancer which is demonstrated by numerous studies. Several 
factors influence the familial aggregation of lung cancer which includes 
similar lifestyles (e. g., smoking habit and diet) and similar 
environment so (e. g., indoor and outdoor air pollution) [31]. 
Forty years ago, the first evidence of familial aggregation of lung 
cancer is reported from an epidemiologic study conducted by 
Tokuhata and Lilienfeld [48]. Several studies reported the familial 
aggregation and increased familial risk for lung cancer, which 
indirectly reporting that genetic factors contribute to susceptibility 
to lung cancer [49]. In never smokers, the degree of relation 
between family history and development of lung cancer has not been 
clearly established [50]. To address this issue, a pooled analysis that 
included 24 case-control studies is conducted by the International 
Lung Cancer Consortium, after adjustment for smoking and other 
potential confounders, 1.51-fold increase in the risk of lung cancer 
occurs among individuals with a first-degree relative with lung 
cancer [51]. The risk of the disease is increased about two to five 
times in persons with a family history of lung cancer is reported by 
several epidemiologic studies, even after controlling for personal 
smoking [52]. There is 2-fold increased risk for lung cancer in 
persons with a family history of lung cancer is reported by a meta-
analysis involving 32 studies and this increased risk is also present 
with non-smokers [20]. In several studies, for both smokers and 
never smokers, family history of lung cancer has been considered as 
a factor for increased risk of non-small cell lung cancer (NSCLC) [50]. 
Previous lung diseases 
Previous lung diseases are a particular set of risk factors that may play 
a major role in lung cancer development. The important previous lung 
diseases are the chronic obstructive pulmonary disease (COPD) 
(including emphysema and bronchitis), pneumonia, and tuberculosis 
causes inflammation of lung tissues and this has been suggested to 
increase the risk of lung cancer. These diseases may develop lung 
cancer through common aetiologies and/or exposures and may act as 
the catalyst in the development of lung neoplasms [53, 54]. Increase in 
risk of lung cancer is also associated with other interstitial lung 
diseases including pulmonary fibrosis, sarcoidosis, systemic sclerosis 
[55]. A recent article found that 13% of female lung cancers among 
lifetime never smokers and 16% among former smokers may be 
attributable to previous lung diseases [52]. 
Cigarette smoking is the major etiological factor for developing COPD 
and lung cancer and there is increasing evidence linking the two 
diseases beyond a common etiological factor [5]. More recently many 
studies in large cohorts have found that COPD is significantly related 
with an increased risk for lung cancer, especially in men [20]. COPD is 
also considered as risk factor for the development of lung cancer like 
other factors including exposure to ETS and exposure to asbestos [56]. 
COPD is considered as an independent risk factor for the development 
of lung carcinoma, particularly for squamous cell carcinoma and in 
smokers with airflow obstruction, lung cancer is up to five times more 
likely to occur than those with normal lung function [5].  
A systematic review and meta-analysis on 39 studies are conducted by 
Darren R Brenner et al. in 2011 and suggests that COPD, emphysema, 
and chronic bronchitis are associated with a significantly increased 
lung cancer risk [57]. The association of COPD, emphysema, and 
chronic bronchitis with the increased risk of lung cancer is verified by 
a case-control study from China. The processes that seen in COPD and 
lung cancer are common which include premature aging in the lungs, 
genetic predisposition to either disease or common pathogenic factors, 
activation of intracellular pathways or epigenetics and this suggests 
high prevalence of lung cancer in COPD patients [58]. A potential 
method enables early detection of lung cancer and thereby to improve 
outcomes is screening of COPD patients for the development of cancer, 
for example through CT scans. The relationship between asthma and 
lung cancer was still uncertain [58]. 
The link of tuberculosis infection and subsequent lung cancer risk is 
examining by authors of a systematic review of 37 case-control and 4 
cohort studies and concluded that at least for adenocarcinoma, there is 
a direct relation exists between tuberculosis infection and subsequent 
lung cancer risk [18]. The Previous diagnosis of TB and pneumonia is 
related with increased lung cancer risk across studies independent of 
smoking is suggested by Darren R Brenner et al. in 2011 [57]. The 
relative risk remained significant for those with a history of 
pneumonia [RR=1.90 (95% CI= 1.10-1.69)] or Tuberculosis [RR=1.90 
(95% CI= 1.45-2.50)], when limited to never smokers [21]. 
Race and ethnicity 
Race often has a strong socioeconomic association and is a complex 
variable. In the United States, the incidence of lung cancer is 
substantially higher among blacks and Native Hawaiians and other 
Polynesians and lower among Japanese Americans and Hispanics 
than among whites is showed by Menck. Among the different ethnic 
and racial groups, the pattern of cigarette smoking is varied and this 
is mainly attributed to the difference in the development of lung 
cancer when considering the race and ethnicity [59]. 
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In a case-control study, Cote and colleagues showed that first degree 
relatives of white persons with early onset lung cancer have a lower 
risk for lung cancer than their black counterparts (17.1% vs 25% 
respectively) [60]. The increasing cigarette smoking exposure 
further amplified these cumulative differences in risk for lung cancer 
among blacks and whites. The mechanisms behind in these observed 
racial or ethnic variations in risk for lung cancer is not clearly 
identified [20]. 
Age 
A number of papers reported the strong influence of age on lung 
cancer among never smokers. As a proxy for duration of exposure to 
various lung carcinogens like cigarette smoke, radon gas etc., age is 
empirically an important predictor of lung cancer in both smokers 
and non-smokers, and arguably age is considered as the most 
important risk factor among never smokers [18]. The median age of 
onset for lung cancer is 66 y old and chances of developing lung 
cancer increase with age [5]. 
A controversy has been existing in the age at which the patients are 
diagnosed with lung cancer in non-smokers. The average age for 
developing lung cancer in never smokers is 59 y [19]. Specifically, 
31.1% of patients with lung cancer are between 65 and 74 y, 29% 
between 75 and 84 y, an 8.3% are 85 y old and older. The mean age 
at the time of diagnosis is found to be over 70 y. The smoking 
prevalence with persons aged 18 to 24 y is 21.4%, 25 to 44 y is 
23.7%, 45 to 64 y is 22.6% and prevalence is 9.3% among persons 
aged 65 y and older. From this, we can understand that the smoking 
prevalence is lowest among persons aged 65 y and older, but more 
than 65% of patients with lung cancer are older than 65. In an 
elderly population, the smoking prevalence is lower and there is 
higher cancer rate, this difference likely reflects heavy smoking 
history in current elderly population [20]. 
Gender 
Among never smokers, the lung cancer incidence rate is higher in 
women than men [3]. Wynder and Graham noted in an early study of 
tobacco smoking that a higher percentage of cancers in non-smokers 
occurred in women than men [61]. The hormones played a major 
role in the development of lung cancer in non-smoking women. In 
cancerous lung tissue, the oestrogen receptors (ER) α and β are 
expressed more frequently than in normal lung tissue. Conversely, 
progesterone receptors are less frequently present in cancerous 
tissue [21]. In the late 1980s, lung cancer surpassed breast cancer as 
the leading cause of cancer deaths in women, and now almost twice 
as many women die of lung cancer than breast cancer [62]. 
Compared with men, there are different clinical features of lung 
cancer in women, such as the percentage of adenocarcinoma 
increases among never smokers, the greater prevalence of 
epidermal growth factor receptor gene (EGFR) mutation in 
adenocarcinomas among never smokers and better prognosis [3]. 
Diet 
It has been suggested that some dietary factors are responsible for 
developing approximately 30% of all cancers [20]. As we understand 
that the major causative factor for the development of lung cancer is 
tobacco smoking, which is the reason for more than 85% of lung 
cancer; however, occupation and diet are also important 
determinants for this disease [63]. There are different studies that 
reported that certain dietary factors may be protective for, and 
others may increase the risk of lung cancer [64]. 
After many years of research on diet and lung cancer, many specific 
micronutrients such as retinol and beta-carotene thought to have 
anti-carcinogenic activity, have been found. In fruits and vegetables, 
most of the micronutrients are commonly present [4]. A large cohort 
study in the Netherlands found that a diet rich in vegetables and 
fruits has been linked to decreased lung cancer incidence, with the 
protective effects are stronger in current smokers than in older 
smokers [20]. In China, report from many case-control studies have 
shown that vegetable intake is providing a protective effect on lung 
cancer and pumpkins and onions had the most consistent protective 
effect [64]. Green vegetables and bananas providing a protective 
effect on the development of lung cancer is reported from another 
study that conducted by Sankaranarayanan [65]. The intake of 
vegetables described as cruciferous, which are rich in 
isothiocyanates, such as broccoli and cabbage, has some protective 
effect against the development of lung cancer [66]. In another study, 
it has also been suggested that consuming fruits or vegetables raw 
rather than cooked is associated with a further reduction in risk for 
lung cancer because carotenoids which present in that vegetables or 
fruits can be destroyed with cooking [67]. Epidemiological studies 
found that use of tomatoes and its products is related with reduced 
risk of cancer development [68]. Overall, it has been suggested that 
low or no consumption of fruits or vegetables have been related with 
up to 3-fold risk for lung cancer [20]. 
On the other hand, many studies reported that animal food products 
and dairy products have a predisposing effect on lung cancer [64]. 
The dietary items that have been suggested as increasing the risk for 
lung cancer include red meat, dairy products, saturated fats, and 
lipids [20]. In a case-control study that conducted by Mostafa 
Hosseini et al. in 2014, found that bread, beef, liver, dairy products, 
vegetable ghee, and animal ghee could be possible predisposing 
factors of the development of lung cancer [69]. In an another study 
reported that, increased risk of squamous cell lung cancer is 
significantly associated with the consumption of food products like 
red meat, beef and fried meet [65]. The risk of lung cancer is 
increased by the consumption of meat, due to the presence of 
mutagenic substances produced mainly during the cooking process 
[70]. In Kerala, South Indian state, a marked increase in risk was 
observed for beef consumption (OR-12.5) [65]. Many studies are 
also reported that low serum concentrations of antioxidants, such as 
vitamins A, C, and E, have been related with the development of lung 
cancer [20, 71]. 
Socioeconomic status 
A person living in hygiene conditions, consuming a proper diet, and 
access to education and health care depends on the financial status 
of an individual. The incidence and prognosis of lung cancer are 
strongly linked with the socioeconomic status [19]. A meta-analysis 
is performed in 2009 and the results of this analysis appear to 
confirm the relation of low education and revenue levels with an 
increased risk of lung cancer (after adjustment of smoking, OR=1.65 
[95% CI-1.19-2.25]). Furthermore, for poor disease outcome and 
poor access to health care, a low socioeconomic status has also been 
considered as a major factor [21]. 
Infections 
There is well-established data are available for the association 
between infection, inflammation and cancer risk [21]. The 
production of pro inflammatory molecules such as reactive oxidative 
species and growth factors are induced by an infection. The relation 
between infections and the risk of a variety of cancers, including 
lung cancer is well established and ample pieces of evidence are 
available [19]. The roles of several pathogens have been studied in 
case of lung cancer [21]. The risk for lung cancer is suspected to 
increase by the history of infectious diseases, such as tuberculosis 
(TB), human immunodeficiency virus (HIV), epstein-barr virus 
(EBV), and human papilloma virus (HPV), and infections with 
Chlamydia pneumonia, Microsporumcanis, and Helicobacter pylori 
[72]. The other viruses like human cytomegalo virus, Simian virus 
40, BK virus, JC virus, and measles virus are suggested as causative 
factor for the development of lung cancer; however, the results have 
remained inconclusive [20]. 
In never smokers, Human Papilloma Virus (HPV) is considered as a 
well-known carcinogen in a particularly virulent form for the 
development of lung cancer [21]. A Taiwanese study that conducted 
on 141 lung cancer patients (versus control) in 2001, the reports 
shown that HPV types 16 and 18 were more frequently present in 
tumours lung tissue than in tissue of the healthy lung. In never 
smoker’s patients aged more than 60 y, the frequency at which HPV 
was found in tumours appeared to be higher. A potential role for 
human papillomavirus (HPV), known to cause carcinoma in other 
tissues is suggested by many studies recently [20]. The hypothesis 
that HIV infection increases lung cancer risk is supported by the 
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review of existing data, with substantial evidence that this effect is 
independent of smoking [73]. 
The association of pulmonary tuberculosis with lung cancer is reported 
by some studies. Increase risk for lung cancer with tuberculosis patients 
is reported by Taiwanese cohort study. Studies continue to report that 
infection with Mycobacterium tuberculosis is associated with a risk of 
lung cancer [RR=1.74 (95% CI=1.48-2.03)], independently of smoking 
status [21]. One study showed that, female never-smokers with TB had 
approximately an eight-fold increase in lung cancer risk than those 
without TB; but not in smokers [74]. Especially in cigarette smoke-
exposed individuals, it has also been suggested that Chlamydia 
pneumonia, a common cause of acute respiratory infection, might be 
involved in lung cancer carcinogenesis [75]. 
CONCLUSION 
Lung cancer considered as the most fatal forms of cancer because 
lack of proper diagnosis and lack of effective treatments and it 
accounts for more deaths than any other cancer types. Even though 
tobacco smoking is the major cause for the development of lung 
cancer, there is alarming rise in incidence of lung cancer among non-
smokers and this indicated that there could be other risk factors 
besides smoking. We understood that the other risk factors were 
also played their role in the development of lung cancer. We 
revealed that exposure to ETS, Various chemicals from occupation 
sites, air pollution can increase the risk for getting lung cancer. The 
dietary agents, previous lung disease, various infections, family 
history etc. can also act as various etiological factors for developing 
lung cancer. These findings can assist us in preventing lung cancer 
from the etiologic level. 
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